Corrigendum to ‘Toll-like receptors in immunity and inflammatory diseases: Past, present, and future’ [International Immunopharmacology 59 (2018) 391–412]

Detalles Bibliográficos
Autor principal: Kumar, Vijay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2018
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445284/
https://www.ncbi.nlm.nih.gov/pubmed/30089605
http://dx.doi.org/10.1016/j.intimp.2018.06.044
_version_ 1784568619910299648
author Kumar, Vijay
author_facet Kumar, Vijay
author_sort Kumar, Vijay
collection PubMed
description
format Online
Article
Text
id pubmed-8445284
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-84452842021-09-16 Corrigendum to ‘Toll-like receptors in immunity and inflammatory diseases: Past, present, and future’ [International Immunopharmacology 59 (2018) 391–412] Kumar, Vijay Int Immunopharmacol Corrigendum Elsevier B.V. 2018-09 2018-07-07 /pmc/articles/PMC8445284/ /pubmed/30089605 http://dx.doi.org/10.1016/j.intimp.2018.06.044 Text en © 2018 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Corrigendum
Kumar, Vijay
Corrigendum to ‘Toll-like receptors in immunity and inflammatory diseases: Past, present, and future’ [International Immunopharmacology 59 (2018) 391–412]
title Corrigendum to ‘Toll-like receptors in immunity and inflammatory diseases: Past, present, and future’ [International Immunopharmacology 59 (2018) 391–412]
title_full Corrigendum to ‘Toll-like receptors in immunity and inflammatory diseases: Past, present, and future’ [International Immunopharmacology 59 (2018) 391–412]
title_fullStr Corrigendum to ‘Toll-like receptors in immunity and inflammatory diseases: Past, present, and future’ [International Immunopharmacology 59 (2018) 391–412]
title_full_unstemmed Corrigendum to ‘Toll-like receptors in immunity and inflammatory diseases: Past, present, and future’ [International Immunopharmacology 59 (2018) 391–412]
title_short Corrigendum to ‘Toll-like receptors in immunity and inflammatory diseases: Past, present, and future’ [International Immunopharmacology 59 (2018) 391–412]
title_sort corrigendum to ‘toll-like receptors in immunity and inflammatory diseases: past, present, and future’ [international immunopharmacology 59 (2018) 391–412]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445284/
https://www.ncbi.nlm.nih.gov/pubmed/30089605
http://dx.doi.org/10.1016/j.intimp.2018.06.044
work_keys_str_mv AT kumarvijay corrigendumtotolllikereceptorsinimmunityandinflammatorydiseasespastpresentandfutureinternationalimmunopharmacology592018391412

Ejemplares similares